Cargando…
Long-term harms from previous use of selective serotonin reuptake inhibitors: A systematic review
BACKGROUND: Millions of people are treated with antidepressants like selective serotonin reuptake inhibitors (SSRIs) or serotonin-norepinephrine reuptake inhibitors (SNRIs). This clinical practice is based on short-term trials that have exaggerated the benefits and underestimated the harms. We also...
Autores principales: | Danborg, P.B., Valdersdorf, M., Gøtzsche, P.C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6839490/ https://www.ncbi.nlm.nih.gov/pubmed/30714974 http://dx.doi.org/10.3233/JRS-180046 |
Ejemplares similares
-
Benefits and harms of antipsychotic drugs in drug-naïve patients with psychosis: A systematic review
por: Danborg, P.B., et al.
Publicado: (2019) -
Sentiment Analysis of Online Reviews for Selective Serotonin Reuptake Inhibitors and Serotonin–Norepinephrine Reuptake Inhibitors
por: Compagner, Chad, et al.
Publicado: (2021) -
Apathy syndrome in a patient previously treated with selective serotonin reuptake inhibitors for depression
por: Kim, Hye-Geum, et al.
Publicado: (2019) -
Long-Term Use of Selective Serotonin Reuptake Inhibitors and Risk of Glaucoma in Depression Patients
por: Chen, Hsin-Yi, et al.
Publicado: (2015) -
Clinical pharmacology of serotonin selective reuptake inhibitors /
por: Preskorn, Sheldon
Publicado: (1996)